Clinical Trials Logo

Filter by:
NCT ID: NCT00776854 Not yet recruiting - Diabetic Foot Ulcer Clinical Trials

Bioburden Reduction of Diabetic Foot Ulcer

Start date: November 2008
Phase: Phase 1
Study type: Interventional

Study to see if a laser can get rid of bacateria called MRSA in your diabetic ulcer

NCT ID: NCT00776464 Not yet recruiting - Onychomycosis Clinical Trials

Treating Onychomychosis

Start date: November 2008
Phase: Phase 2/Phase 3
Study type: Interventional

A study to treat 4 toes at a time to eliminate Onychomycosis

NCT ID: NCT00763828 Not yet recruiting - Clinical trials for ST-Elevation Myocardial Infarction

Can Hypothermia be Incorporated Into Primary Angioplasty for Heart Attack?

CHIPAHA
Start date: January 28, 2024
Phase: N/A
Study type: Interventional

The hypothesis of this study is that consciously sedated patients suffering from ST-elevation myocardial infarction can be rapidly and safely cooled to a state of therapeutic hypothermia (32 to 34 degrees C) using the LRS ThermoSuit System prior to percutaneous coronary intervention.

NCT ID: NCT00763308 Not yet recruiting - Clinical trials for Cardiovascular Diseases

A Web-Based Cardiovascular Intervention for the Workplace

Start date: April 2009
Phase: Phase 1
Study type: Interventional

Heart disease is the leading cause of death in the United States, accounting for approximately 700,000 deaths a year. Heart disease can take many forms, including heart attacks, coronary artery disease, aneurysms, high blood pressure, and strokes. However, people can change things in their life to reduce the risk of getting heart disease. This study will first create an Internet-based program to help teach people about reducing heart disease risk and will then test the program in a workplace setting.

NCT ID: NCT00761904 Not yet recruiting - Hypertension Clinical Trials

The Effect of Providing Free Samples of Generic Cardiovascular Medications to Physicians

SAMPLES
Start date: December 2010
Phase: N/A
Study type: Interventional

In this randomized controlled trial, we will provide primary care physicians with free samples of highly effective generic cardiovascular medications. We will test whether this intervention will stimulate cost-effective prescribing, reducing drug costs and improving adherence to essential cardiovascular medications.

NCT ID: NCT00756483 Not yet recruiting - Arthroplasty Clinical Trials

Stability Plus - Outcomes From Extended Continuum of Care

Start date: October 2008
Phase: N/A
Study type: Observational

Basic Protocol 1. Identify participant(s) 2. Request patient participation/Acquire Consent 3. Register patient at www.stabilityplus.net through the LOGIN tab - Patient ID (Name/Initials/SSN or any combination thereof) - Gender - Age - Surgical Procedure - Date of Surgery - Select Basic Exercise Program that corresponds with Surgical Procedure 4. Perform Initial Assessment using Basic Exercises for the Surgical Procedure 5. Enter Assessment Data at www.stabilityplus.net (through the LOGIN tab/Portal) 6. Within portal, modify Basic Exercise Program to create customized Stability Plus prescription for the patient 7. Monitor patient progress through Stability Plus portal.

NCT ID: NCT00755989 Not yet recruiting - Wounds Clinical Trials

Use of Morphine Gel Topically in Patients With Stage 2-3 Wounds

Start date: December 2008
Phase: Phase 3
Study type: Interventional

Morphine gel applied topically to wounds will reduce wound pain and decrease patients use of oral and intravenous pain medications, therefore reducing side effects.

NCT ID: NCT00753467 Not yet recruiting - Hepatitis B Clinical Trials

A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B

Start date: September 2008
Phase: Phase 2
Study type: Interventional

Open-label, prospective, two part study evaluating IFN-γ 1b at a dose of 200μg by subcutaneous injection every day either alone or in combination with Adefovir dipivoxil or Adefovir dipivoxil alone at a dose of 10mg QD in patients with chronic Hepatitis B.

NCT ID: NCT00743834 Not yet recruiting - Clinical trials for Obsessive Compulsive Disorder

Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD)

Start date: September 2008
Phase: Phase 4
Study type: Interventional

This study will test the hypotheses that: 1. 12 weeks of Luvox-CR plus web-based Cognitive-Behavioral Therapy (CBT) [CT-STEPS] will produce greater symptom relief of OCD than treatment with Luvox-CR alone; and, 2. subjects receiving 12 weeks of CT-STEPS added to Luvox-CR treatment after 12-weeks of Luvox-CR monotherapy will experience greater OCD symptom relief (from weeks 12-24) than those continuing Luvox-CR treatment and having access to CT-STEPS from week one. 3. subjects who begin CT-STEPS at week 12 will be more likely to complete it than those who begin CT-STEPS at baseline.

NCT ID: NCT00737152 Not yet recruiting - Clinical trials for Type II Diabetes Mellitus

Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus

ASI-DMII
Start date: July 2011
Phase: Phase 2
Study type: Interventional

Rationale: RAS 130 is an anti-diabetic agent used to lower the blood glucose level in Type II Diabetes mellitus (non-insulin-dependent diabetes) patients with proper diet and exercise. RAS 130 works by restoring proper response to insulin in the body. RAS 130 acts primarily by increasing insulin sensitivity which improves glycemic index. It is presumed that RAS 130 does not cause cardiovascular side effects if it is given to Type II diabetes mellitus patients leading a healthy life style. Specifically, controlling diet is done according to American Diabetic Association & American Heart Association guidelines and also through doing aerobic exercises. Guideline for aerobic exercise is given in the design of the study. Exercise is helpful in controlling body weight which can lower the risk for heart disease. Diabetes itself is one of the compounding factors for heart diseases. Exercise helps lowering the LDL cholesterol and raising the HDL cholesterol which is required to prevent heart diseases and achieve a better quality of life. Purpose: The aim of this study is to prospectively assess and evaluate the cardiovascular side effects and reduction of blood glucose levels in the Type II Diabetes mellitus patients treated with RAS 130, who either met, or failed to meet criteria for diet and exercise.